期刊文献+

中西医结合治疗晚期肺腺癌32例疗效观察 被引量:12

原文传递
导出
摘要 目的:观察中西医结合治疗中晚期肺腺癌的临床疗效。方法:将64例符合入选标准的中晚期肺腺癌患者随机分为治疗组和对照组各32例,治疗组采用益肺败毒汤联合吉非替尼治疗,对照组采用吉非替尼治疗。结果:治疗组有效率(CR+PR)为28.13%、(CR+PR+SD)为90.63%,均明显优于对照组(P<0.05);且治疗组生活质量也明显优于对照组(P<0.05)。结论:中西医结合治疗中晚期肺腺癌有较好疗效。
出处 《湖南中医杂志》 2011年第6期25-26,共2页 Hunan Journal of Traditional Chinese Medicine
  • 相关文献

参考文献3

  • 1孙燕,石远凯.临床肿瘤内科手册(第5版)[M].北京:人民卫生出版社,2008,388.
  • 2王燕,张湘茹,王彬,王子平,储大同,孙燕.吉非替尼治疗69例老年肺腺癌的临床分析[J].中国肺癌杂志,2008,11(1):137-141. 被引量:10
  • 3Liam CK, Pang YK, Leow CH, et al. Changes in the distribution of lung cancer cell types and patient demography in a developing multiracial Asian country:experience of a university teaching hos- pital[ J]. Lung Cancer,2006,53 ( 1 ) :23 - 30.

二级参考文献14

  • 1Liam CK,Pang YK,Leow CH,et al.Changes in the distribution of lung cancer cell types and patient demography in a developing multiracial Asian country:experience of a university teaching hospital.Lung Cancer,2006,53(1):23-30.
  • 2Owonikoko TK,Ragin CC,Belani CP,et al.Lung cancer in elderly patients:an analysis of the surveillance,epidemiology,and end results database.J Clin Oncol,2007,25(35):5570-5577
  • 3Gridelli C,Malone P,Illiano A,et al.Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer.the MILES-2P studies.J Clin Oncol,2007,25(29):4663-4669.
  • 4NCCN Clinical Practice Guidline in Oncology:Non-small Cell Lung Cancer Vision 2,2007.
  • 5Hann CL,Brahmer JR."Who should receive epidermal growth factor receptor inhihitors for non-small cell lung cancer and when?"Curr Treat Options Oneol,2007,8(1):28-37.
  • 6Cappuzzo F,Toschi L,Finocchiaro G,et al.Surrogate predictive biomarkers for response to anti-EGFR agents:state of the art and challenges.Int J Biol Markers,2007,22(1 Suppl 4):S10-S23.
  • 7Chang GC,Tsai CM,Chen KC,et al.Predictive factors of geftinib antitumor activity in East Asian advanced non-small cell lung cancer patients.J Thorac Oncol,2006,1(6):520-525.
  • 8Satouchi M,Negoro S,Funada Y,et al.Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer(NSCLC)treated with gefitinib.Br J Cancer,2007,96(8):1191-1196.
  • 9Kimura H,Kasahara K,Shibata K,et al.EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer,J Thorac Oncol,2006,1(3):260-267.
  • 10Asahina H,Yamazaki K,Kinoshita I,et al.A phase Ⅱ trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations.Br J Cancer,2006,95(8):998-1004

共引文献9

同被引文献168

引证文献12

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部